Drugs / QX-4533
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07678463 | Jul → Dec 2026 expected | — | QuantX Biosciences, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QX-4533 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07678463 ↗ |
| Route | Oral | “following oral administration of single and multiple ascending doses” NCT07678463 ↗ |